Clear Secure, Inc.
YOU NYSE Services-Prepackaged Software Financials FY2019βFY2025
What Clear Secure, Inc. does
No business description yet.
- Legal name
- Clear Secure, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001856314-26-000006
0001856314
Revenue and margins
Clear Secure, Inc. had $901M of revenue in fiscal 2025, up 16.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $343M in fiscal 2025, 38.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Clear Secure, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Clear Secure, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $615M | $705M | $723M | $609M | $700M |
| Current ratio | 2.5x | 1.9x | 1.4x | 1.0x | 1.0x |
| Quick ratio | 2.5x | 1.9x | 1.4x | 1.0x | 1.0x |
| Total assets | $813M | $1.0B | $1.0B | $1.2B | $1.3B |
| Total liabilities | $273M | $527M | $676M | $957M | $1.1B |
| Shareholders' equity | $278M | $291M | $233M | $198M | $178M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β | 1.3% | β20.2% | β25.3% | β18.9% | β11.3% | β21.1% |
| Altman Z'' | β | β10.18 | 3.11 | 1.60 | 1.63 | 1.24 | 1.45 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $192M | $231M | $254M | $437M | $614M | $770M | $901M |
| Research and development | $21.2M | $32.0M | $47.5M | $66.8M | $74.4M | $73.4M | $72.4M |
| Operating income | β$56.2M | β$18.9M | β$115M | β$129M | $20.1M | $123M | $186M |
| Pretax income | β$54.2M | β$9.3M | β$115M | β$117M | $50.6M | $66.6M | $206M |
| Income tax | $0.0M | $0.0M | $0.2M | β$2.1M | $0.7M | β$159M | $37.9M |
| Net income | β$54.2M | β$9.3M | β$36.1M | β$65.6M | $28.1M | $170M | $109M |
| Cash flow | |||||||
| Cash from operations | $16.6M | β$12.3M | $69.7M | $168M | $225M | $296M | $372M |
| Capital expenditure | $14.7M | $16.5M | $28.1M | $31.4M | $25.6M | $12.0M | $29.3M |
| Free cash flow | $1.9M | β$28.8M | $41.6M | $137M | $199M | $284M | $343M |
| Depreciation and amortization | $7.3M | $9.4M | $12.4M | $18.8M | $21.6M | $26.5M | $34.6M |
| Stock-based compensation | $14.7M | $3.4M | $36.5M | $138M | $37.3M | $35.3M | $38.9M |
| Acquisitions | $0.0M | $0.0M | $75.8M | $0.0M | $3.8M | $0.0M | $0.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $236M | $154M | $615M | $705M | $723M | $609M | $700M |
| Current assets | β | $172M | $653M | $742M | $770M | $662M | $765M |
| Current liabilities | β | $146M | $265M | $397M | $552M | $643M | $760M |
| Property and equipment, net | β | $35.2M | $44.5M | $57.9M | $62.6M | $56.9M | $59.3M |
| Goodwill | β | $0.0M | $59.8M | $58.8M | $62.8M | $62.8M | $62.7M |
| Intangible assets | β | $1.6M | $22.9M | $22.3M | $20.8M | $15.3M | $2.8M |
| Total assets | β | $232M | $813M | $1.0B | $1.0B | $1.2B | $1.3B |
| Total liabilities | β | $150M | $273M | $527M | $676M | $957M | $1.1B |
| Shareholders' equity | β | β$487M | $278M | $291M | $233M | $198M | $178M |
| Margins | |||||||
| Operating margin | β29.2% | β8.2% | β45.3% | β29.5% | 3.3% | 16.0% | 20.7% |
| EBITDA margin | β25.4% | β4.1% | β40.4% | β25.2% | 6.8% | 19.4% | 24.5% |
| Net margin | β28.2% | β4.0% | β14.2% | β15.0% | 4.6% | 22.0% | 12.1% |
| FCF margin | 1.0% | β12.5% | 16.4% | 31.3% | 32.5% | 36.8% | 38.1% |
| Returns | |||||||
| Return on capital employed | β | β22.0% | β21.0% | β20.2% | 4.1% | 22.3% | 34.3% |
| Return on equity | β | β | β | β23.1% | 10.7% | 78.6% | 58.1% |
| Return on assets | β | β4.0% | β6.9% | β7.1% | 2.7% | 15.2% | 8.7% |
| Return on tangible equity | β | β | β18.5% | β31.2% | 18.8% | 141.0% | 97.2% |
| Growth | |||||||
| Revenue growth | β | 20.0% | 10.0% | 72.3% | 40.3% | 25.6% | 16.9% |
| Net income growth | β | β | β | β | β | 503.7% | β35.7% |
| FCF growth | β | β1,624.3% | β | 229.5% | 45.7% | 42.2% | 21.0% |
| Financial health | |||||||
| Current ratio | β | 1.2x | 2.5x | 1.9x | 1.4x | 1.0x | 1.0x |
| Quick ratio | β | 1.2x | 2.5x | 1.9x | 1.4x | 1.0x | 1.0x |
| Capital allocation | |||||||
| Capex / revenue | 7.6% | 7.2% | 11.1% | 7.2% | 4.2% | 1.6% | 3.3% |
| Stock comp / revenue | 7.6% | 1.5% | 14.4% | 31.7% | 6.1% | 4.6% | 4.3% |
| Quality scores | |||||||
| Altman Z'' | β | β10.2 | 3.1 | 1.6 | 1.6 | 1.2 | 1.5 |
| Accruals ratio | β | 1.3% | β20.2% | β25.3% | β18.9% | β11.3% | β21.1% |
Source: SEC EDGAR XBRL filings (CIK 0001856314). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.